Re: Bontzos et al.: Nonresponders to Ranibizumab Anti-VEGF Treatment Are Actually Short-term Responders: A Prospective Spectral-Domain OCT Study (Ophthalmol Retina. 2020;4:1138-1145)

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)e3
JournalOphthalmology Retina
Volume5
Issue number3
DOIs
StatePublished - Mar 2021

ASJC Scopus subject areas

  • Ophthalmology

Cite this